Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc.verified

ADXS

Price:

$0.1036

Market Cap:

$4.41M

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Industry

Biotechnology

IPO Date

2020-05-08

Stock Exchange

OTC

Ticker

ADXS

The PE Ratio as of December 2025 (TTM) for Ayala Pharmaceuticals, Inc. (ADXS) is -0.01

According to Ayala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -92.28% compared to the average of -0.13 of the last 4 quarters.

Ayala Pharmaceuticals, Inc. (ADXS) Historical PE Ratio (quarterly & annually)

How has ADXS PE Ratio performed in the past?

The mean historical PE Ratio of Ayala Pharmaceuticals, Inc. over the last ten years is -164.05. The current -0.01 PE Ratio has changed -99.39% with respect to the historical average. Over the past ten years (40 quarters), ADXS's PE Ratio was at its highest in in the January 2019 quarter at 41.60. The PE Ratio was at its lowest in in the July 2015 quarter at -768.21.

Quarterly (TTM)
Annual

Average

-164.05

Median

-12.67

Minimum

-823.93

Maximum

-0.08

Ayala Pharmaceuticals, Inc. (ADXS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ayala Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 805.71%

Maximum Annual PE Ratio = -0.08

Minimum Annual Increase = -96.90%

Minimum Annual PE Ratio = -823.93

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.08-45.31%
2022-0.15-84.87%
2022-1.00-38.03%
2021-1.62120.53%
2020-0.74-96.90%
2019-23.72-77.13%
2018-103.75-70.23%
2017-348.453.38%
2016-337.08-59.09%
2015-823.93805.71%

Ayala Pharmaceuticals, Inc. (ADXS) Average PE Ratio

How has ADXS PE Ratio performed in the past?

The current PE Ratio of Ayala Pharmaceuticals, Inc. (ADXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.41

5-year avg

-0.72

10-year avg

-164.05

Ayala Pharmaceuticals, Inc. (ADXS) PE Ratio vs. Peers

How is ADXS’s PE Ratio compared to its peers?

Ayala Pharmaceuticals, Inc.’s PE Ratio is less than Health Sciences Group, Inc. (-0.00), greater than Appili Therapeutics Inc. (-1.32), greater than Algernon Pharmaceuticals Inc. (-1.32), greater than Restart Life Sciences Corp. (-2.72), less than ReNeuron Group plc (-0.01), greater than America Great Health (-1.95), greater than VG Life Sciences Inc. (-3.15), greater than Universal Ibogaine Inc. (-0.18), greater than Regen BioPharma, Inc. (-0.25), greater than Agentix Corp. (-1.22),

Build a custom stock screener for Ayala Pharmaceuticals, Inc. (ADXS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ayala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ayala Pharmaceuticals, Inc. (ADXS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ayala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Ayala Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Ayala Pharmaceuticals, Inc. (ADXS)?

What is the highest PE Ratio for Ayala Pharmaceuticals, Inc. (ADXS)?

What is the 3-year average PE Ratio for Ayala Pharmaceuticals, Inc. (ADXS)?

What is the 5-year average PE Ratio for Ayala Pharmaceuticals, Inc. (ADXS)?

How does the current PE Ratio for Ayala Pharmaceuticals, Inc. (ADXS) compare to its historical average?